Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Vincenzo Andreone"'
Autor:
Giuseppe Leone, Massimo Muto, Flavio Giordano, Gianluigi Guarnieri, Antonio Di Donna, Camilla Russo, Daniele Giuseppe Romano, Paolo Candelaresi, Giovanna Servillo, Emanuele Spina, Antonio De Mase, Vincenzo Andreone, Mario Muto
Publikováno v:
Neurointervention. 18:30-37
Purpose: A direct aspiration, first pass technique (ADAPT) has been introduced as a rapid and safe thrombectomy strategy in patients with intracranial large vessel occlusion (LVO). The aim of the study is to determine the technical feasibility, safet
Autor:
Alfonso Rubino, Pia Bernardo, Carmela Russo, Celeste Tucci, Luigia D'Amato, Veronica Piccolo, Vincenzo Andreone, Pasquale Striano, Geremia Zito Marinosci, Antonio Varone
Publikováno v:
Brain and Development. 45:87-91
Autor:
Capuano, Giorgia Teresa Maniscalco, Daniele Di Giulio Cesare, Valerio Liguori, Valentino Manzo, Elio Prestipino, Simona Salvatore, Maria Elena Di Battista, Ornella Moreggia, Antonio Rosario Ziello, Vincenzo Andreone, Cristina Scavone, Annalisa
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 13; Pages: 4236
Since the beginning of the mass immunization of patients with multiple sclerosis (MS), many data on the efficacy and safety of COVID-19 vaccines have been produced. Considering that MS is an autoimmune disease and that some disease-modifying therapie
Autor:
Michele Romoli, Eleonora Matteo, Ludovica Migliaccio, Mauro Gentile, Maria Giulia Mosconi, Giuseppe Maria Scura, Marcello Naccarato, Enrico Colangeli, Paolo Candelaresi, Vincenzo Andreone, Fabrizio Giammello, Rosa Fortunata Musolino, Cristina Dell’Aera, Federica Nicoletta Sepe, Edoardo Pronello, Leonardo Barbarini, Marcella Caggiula, Federica Rizzo, Marco Petruzzellis, Elisa Giorli, Maria Luisa Zedde, Sabrina Anticoli, Marilena Mangiardi, Mario Muto, Francesco Diana, Maria Vittoria De Angelis, Anna Digiovanni, Letizia Concari, Sara La Gioia, Maria Sessa, Sara Biguzzi, Francesco Cordici, Marco Longoni, Maria Ruggiero, Silvia Cenciarelli, Paolo Eusebi, Simona Sacco, Valeria Caso, Maurizio Paciaroni, Stefano Ricci, Andrea Zini, Danilo Toni, David Giannandrea
Publikováno v:
Eur Stroke J
Introduction: Recent anticoagulant intake represents a contraindication for thrombolysis in acute ischemic stroke. Idarucizumab reverses the anticoagulant effect of dabigatran, potentially allowing for thrombolysis. This nation-wide observational coh
Autor:
Antonio De Mase, Paolo Candelaresi, Emanuele Spina, Flavio Giordano, Stefano Barbato, Giovanna Servillo, Elio Prestipino, Alessandra Fasolino, Gianluigi Guarnieri, Giuseppe Leone, Massimo Muto, Mario Muto, Vincenzo Andreone
Publikováno v:
Neurointervention.
Endovascular thrombectomy is the standard treatment in selected patients with acute ischemic stroke and large vessel occlusion, but continuous improvement in angiographic and clinical outcome is still needed. Intra-arterial thrombolysis has been test
Autor:
Emanuele Spina, Paolo Candelaresi, Giampiero Volpe, Florindo D’Onofrio, Daniele Spitaleri, Gioacchino Martusciello, Giovanni Piccirillo, Francesco Briganti, Mario Muto, Michele Feleppa, Marco Sparaco, Andrea Manto, Teresa Cuomo, Salvatore Ascione, Patrizia Ripa, Daniele Giuseppe Romano, Vincenzo Andreone, Fiore Manganelli, Rosa Napoletano
Publikováno v:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 43(12)
Background According to the last Italian report by the Ministry of Health in 2018, the estimated number of acute ischemic strokes (AIS) in Campania is 10,000/year, with an expected number of 1390 intravenous thrombolysis (IVT) and 694 mechanical thro
Autor:
Giorgia Teresa Maniscalco, Anne Lise Ferrara, Antonietta Liotti, Valentino Manzo, Maria Elena Di Battista, Simona Salvatore, Daniela Graziano, Assunta Viola, Gerardino Amato, Ornella Moreggia, Daniele Di Giulio Cesare, Gennaro Alfieri, Walter Di Iorio, Gennaro Della Rocca, Vincenzo Andreone, Veronica De Rosa
Publikováno v:
Multiple sclerosis and related disorders. 62
The persistence of the severe acute respiratory syndrome coronavirus (SARS-CoV)-2 pandemic, partly due to the appearance of highly infectious variants, has made booster vaccinations necessary for vulnerable groups. Here, we present data regarding the
Autor:
Giorgia Teresa Maniscalco, Antonietta Liotti, Anne Lise Ferrara, Elio Prestipino, Simona Salvatore, Maria Elena Di Battista, Ornella Moreggia, Daniele Di Giulio Cesare, Roberta Vastano, Martina Belardo, Massimo Napolitano, Angelo Ranieri, Katia Longo, Vincenzo Andreone, Veronica De Rosa
Publikováno v:
Multiple Sclerosis and Related Disorders. 68:104371
It remains unclear how vaccine doses and combinations of vaccination and infection affect the magnitude and quality of immune responses, particularly against novel SARS-CoV-2 variants in subjects with immune-related disorders, such as people with mul
Autor:
Giorgia Teresa Maniscalco, Cristina Scavone, Annamaria Mascolo, Valentino Manzo, Elio Prestipino, Gaspare Guglielmi, Maria Luisa Aiezza, Santolo Cozzolino, Adele Bracco, Ornella Moreggia, Daniele Di Giulio Cesare, Antonio Rosario Ziello, Angela Falco, Marida Massa, Massimo Majolo, Eliana Raiola, Roberto Soprano, Giuseppe Russo, Giuseppe Longo, Vincenzo Andreone, Annalisa Capuano
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 22; Pages: 6855
In the current COVID-19 pandemic, patients diagnosed with multiple sclerosis (MS) are considered to be one of the highest priority categories, being recognized as extremely vulnerable people. For this reason, mRNA-based COVID-19 vaccines are strongly
Autor:
Maria Petracca, Serena Ruggieri, Elena Barbuti, Antonio Ianniello, Roberta Fantozzi, Giorgia Teresa Maniscalco, Vincenzo Andreone, Doriana Landi, Girolama Alessandra Marfia, Maria Di Gregorio, Rosa Iodice, Leonardo Sinisi, Elisabetta Maida, Rosanna Missione, Cinzia Coppola, Simona Bonavita, Giovanna Borriello, Diego Centonze, Giacomo Lus, Carlo Pozzilli, Elisabetta Signoriello
Cladribine administration has been approved for the treatment of relapsing-remitting multiple sclerosis (MS) in 2017; thus, data on cladribine in a real-world setting are still emerging.We report on cladribine effectiveness, safety profile, and treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d068bc5be6ed41d91f13454f3edfb54
http://hdl.handle.net/11573/1652789
http://hdl.handle.net/11573/1652789